XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Balances at beginning of period at Dec. 31, 2020 $ 15,815 $ 10 $ 308,065 $ (291,163) $ (1,097)
Balances at beginning of period (in shares) at Dec. 31, 2020   9,743,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock through equity distribution agreement, net of offering costs 3,025 $ 1 3,024    
Issuance of common stock through equity distribution agreement, net of offering costs (in shares)   1,186,000      
Issuance of common stock from vesting of restricted stock units (in shares)   12,000      
Tax withholding related to vesting of restricted stock units (23)   (23)    
Stock-based compensation expense 276   276    
Net loss (2,212)     (2,212)  
Foreign currency translation adjustments (51)       (51)
Balances at end of period at Mar. 31, 2021 16,830 $ 11 311,342 (293,375) (1,148)
Balances at end of period (in shares) at Mar. 31, 2021   10,941,000      
Balances at beginning of period at Dec. 31, 2020 15,815 $ 10 308,065 (291,163) (1,097)
Balances at beginning of period (in shares) at Dec. 31, 2020   9,743,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss 12,944        
Balances at end of period at Dec. 31, 2021 46,258 [1] $ 15 351,394 (304,107) (1,044)
Balances at end of period (in shares) at Dec. 31, 2021   15,532,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from vesting of restricted stock units (in shares)   11,000      
Tax withholding related to vesting of restricted stock units (29)   (29)    
Stock-based compensation expense 883   883    
Net loss (1,999)     (1,999)  
Foreign currency translation adjustments 3       3
Balances at end of period at Mar. 31, 2022 $ 45,116 $ 15 $ 352,248 $ (306,106) $ (1,041)
Balances at end of period (in shares) at Mar. 31, 2022   15,543,000      
[1] Derived from the Company’s audited consolidated financial statements as of December 31, 2021.